This result suggests that either the cytotoxic activity of S14506 may be connected to the activation of the 5-HT1A receptor biochemical transduction pathway in the prostate, but not in neuroblastoma cancer cells, or that a receptor antagonist may be transduction pathway-specific. Here, HTR1A is linked to cancer.